Gloria Nam

Gloria Nam is an experienced finance professional currently serving as Corporate Controller at Metagenomi since October 2022. Previously, Gloria held roles as Consultant and Corporate Controller at 4D Molecular Therapeutics from October 2018 to December 2021, and as Assistant Controller and Senior Manager of SEC Reporting and SOX Compliance at Five Prime Therapeutics, Inc. from September 2015 to October 2018. Gloria's earlier experience includes positions as Assurance Manager and Senior Assurance Associate at BDO USA, LLP, where responsibilities encompassed managing client compliance with Sarbanes-Oxley regulations, reviewing SEC financial reporting, and conducting audits for various industries. Gloria holds a B.S. in Business Administration from the University of California, Berkeley, obtained in 2008.